• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

294.28 +19.58 (+7.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,428,905
Open 284.65
Bid (Size) 294.26 (8)
Ask (Size) 294.99 (1)
Prev. Close 274.70
Today's Range 283.01 - 296.60
52wk Range 266.98 - 417.81
Shares Outstanding 44,891,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
Today 7:00 EDT
From United Therapeutics Corporation
Via Business Wire
Forecasting The Future: 8 Analyst Projections For United Therapeutics
July 31, 2025
 
Via Benzinga

Performance

YTD
-18.3%
-18.3%
1 Month
+1.2%
+1.2%
3 Month
+0.1%
+0.1%
6 Month
-16.5%
-16.5%
1 Year
-6.1%
-6.1%

More News

Read More
Earnings Summary on United Therapeutics
July 31, 2025
Via The Motley Fool
Topics Intellectual Property
United Therapeutics Stock Slides On Q2 Earnings: The Details
July 30, 2025
Via Benzinga
United Therapeutics (NASDAQ:UTHR) Misses Q2 Revenue Estimates
July 30, 2025
Via StockStory
Earnings Scheduled For July 30, 2025
July 30, 2025
Via Benzinga
Preview: United Therapeutics's Earnings
July 29, 2025
Via Benzinga
United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results
July 30, 2025
From United Therapeutics Corporation
Via Business Wire
What To Expect From United Therapeutics’s (UTHR) Q2 Earnings
July 28, 2025
Via StockStory
Topics Artificial Intelligence
Insmed Is Trading At A 25-Year High. Will Its 'Skeleton Key' Work?
July 24, 2025
Via Investor's Business Daily
UNITED THERAPEUTICS CORP (NASDAQ:UTHR): A Prime Value Pick with Strong Fundamentals and Undervalued Potential
July 24, 2025
Via Chartmill
Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The Rest
July 16, 2025
Via StockStory
Topics Artificial Intelligence
United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025
July 16, 2025
From United Therapeutics Corporation
Via Business Wire
Q1 Earnings Roundup: Gilead Sciences (NASDAQ:GILD) And The Rest Of The Therapeutics Segment
July 15, 2025
Via StockStory
Topics Artificial Intelligence
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)
July 15, 2025
Via StockStory
Topics Artificial Intelligence
1 Cash-Producing Stock with Impressive Fundamentals and 2 to Keep Off Your Radar
July 15, 2025
Via StockStory
Unpacking Q1 Earnings: BioMarin Pharmaceutical (NASDAQ:BMRN) In The Context Of Other Therapeutics Stocks
July 14, 2025
Via StockStory
Topics Artificial Intelligence
UNITED THERAPEUTICS CORP (NASDAQ:UTHR) – A Strong Candidate for GARP Investors
July 09, 2025
Via Chartmill
1 Value Stock with Impressive Fundamentals and 2 to Turn Down
July 09, 2025
Via StockStory
UNITED THERAPEUTICS CORP (NASDAQ:UTHR) - A Potential Undervalued Biotech Stock
July 02, 2025
Via Chartmill
1 Mid-Cap Stock with Exciting Potential and 2 to Ignore
July 01, 2025
Via StockStory
Deep Dive Into United Therapeutics Stock: Analyst Perspectives (9 Ratings)
June 30, 2025
Via Benzinga
Disney To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday
June 30, 2025
Via Benzinga
United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver
June 24, 2025
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension
June 23, 2025
From United Therapeutics Corporation
Via Business Wire

Frequently Asked Questions

Is United Therapeutics Corporation - Common Stock publicly traded?
Yes, United Therapeutics Corporation - Common Stock is publicly traded.
What exchange does United Therapeutics Corporation - Common Stock trade on?
United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for United Therapeutics Corporation - Common Stock?
The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
What is the current price of United Therapeutics Corporation - Common Stock?
The current price of United Therapeutics Corporation - Common Stock is 294.28
When was United Therapeutics Corporation - Common Stock last traded?
The last trade of United Therapeutics Corporation - Common Stock was at 08/01/25 04:00 PM ET
What is the market capitalization of United Therapeutics Corporation - Common Stock?
The market capitalization of United Therapeutics Corporation - Common Stock is 13.21B
How many shares of United Therapeutics Corporation - Common Stock are outstanding?
United Therapeutics Corporation - Common Stock has 13B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap